Abstract
During the decade of the 1970s, new controlled-release technology continued to emerge from research laboratories around the world. A few controlled-release formulations and devices have already reached the market place, and many others are currently undergoing premarketing trials. One might say that controlled release has transgressed from its infancy through its childhood, and it is rapidly maturing to occupy a vital position in many important industries. The future of controlled release appears bright indeed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
J. Folkman and D.M. Long, Jr., J. Surg. Res. 4: 139 (1964).
R.W. Baker and H.K. Lonsdale, in: “Controlled Release of Biologically Active Agents,” A.C. Tanquary and R.E. Lacey, eds., Plenum Press, New York (1974). pp. 195–224.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cowsar, D.R. (1981). Controlled Release: Benefits vs. Risks. In: Lewis, D.H. (eds) Controlled Release of Pesticides and Pharmaceuticals. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0737-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0737-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0739-7
Online ISBN: 978-1-4757-0737-3
eBook Packages: Springer Book Archive